| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | T Pincus | |
| T Sokka | |||
| B Abelson | |||
| P433 | issue | 5 Suppl 51 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | S35-61 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | Mortality in rheumatoid arthritis: 2008 update | |
| P478 | volume | 26 |
| Q34247086 | A genome-wide homozygosity association study identifies runs of homozygosity associated with rheumatoid arthritis in the human major histocompatibility complex |
| Q36449974 | A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. |
| Q33923332 | A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. |
| Q33765844 | Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. |
| Q37402723 | Alterations to the middle cerebral artery of the hypertensive-arthritic rat model potentiates intracerebral hemorrhage. |
| Q91740558 | Amyloid Goiter in a Patient with Rheumatoid Arthritis and End-Stage Renal Disease |
| Q33865776 | Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients |
| Q54265432 | Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis. |
| Q33893385 | Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance |
| Q64251395 | Assessment of Cardiovascular Disease Risk and Therapeutic Patterns among Urban Black Rheumatoid Arthritis Patients |
| Q28386085 | Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis |
| Q35025293 | Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q55413719 | Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
| Q36943015 | Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study |
| Q34982012 | Biomarkers predicting a need for intensive treatment in patients with early arthritis |
| Q38828456 | Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis. |
| Q53393852 | Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial. |
| Q38115190 | Can bone loss in rheumatoid arthritis be prevented? |
| Q64929171 | Cardiorespiratory fitness in patients with rheumatoid arthritis is associated with the patient global assessment but not with objective measurements of disease activity. |
| Q47940789 | Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China |
| Q64103936 | Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis |
| Q38980705 | Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis |
| Q38401295 | Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort |
| Q55396055 | Chemokine C-C Motif Ligand 4 Gene Polymorphisms Associated with Susceptibility to Rheumatoid Arthritis. |
| Q45796102 | Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis |
| Q37693747 | Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis |
| Q55383962 | Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. |
| Q36513993 | Co-morbidity in patients with early rheumatoid arthritis - inflammation matters |
| Q52667978 | Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis. |
| Q54246292 | Comorbidities in Spondyloarthritis. |
| Q50114438 | Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study |
| Q34587411 | Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial |
| Q57461358 | Correlation of the Multi-Biomarker Disease Activity Score with Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis |
| Q38401848 | Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? |
| Q38191519 | Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis |
| Q41225289 | Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study. |
| Q30715768 | Does the "Hispanic paradox" occur in rheumatoid arthritis? Survival data from a multiethnic cohort |
| Q36113215 | Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy |
| Q37383148 | Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis |
| Q49282700 | Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q37774304 | Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality |
| Q99638169 | Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review |
| Q34035693 | Identification of undiagnosed inflammatory arthritis in a community health fair screen |
| Q47625115 | Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis |
| Q38658483 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis |
| Q39057277 | Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. |
| Q61449138 | Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q35152581 | Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study |
| Q90171583 | Intracerebral Hemorrhage in a Patient with Untreated Rheumatoid Arthritis: Case Report and Literature Review |
| Q84335976 | Is rheumatoid arthritis really getting less severe? |
| Q37663873 | Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy |
| Q58761625 | Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence |
| Q33873068 | Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. |
| Q28085725 | Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials |
| Q44461682 | Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center |
| Q35800079 | Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates |
| Q37709979 | Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study |
| Q34481954 | Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. |
| Q33645362 | Multi-dimensional health assessment questionnaire in China: reliability, validity and clinical value in patients with rheumatoid arthritis |
| Q37916426 | Nanotherapeutic approaches for the treatment of rheumatoid arthritis |
| Q34699641 | No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register |
| Q38104641 | Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about |
| Q37473766 | Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy |
| Q50599640 | Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. |
| Q35320040 | Poor physical function, pain and limited exercise: risk factors for premature mortality in the range of smoking or hypertension, identified on a simple patient self-report questionnaire for usual care |
| Q48069664 | Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis |
| Q36093378 | Preserved skeletal muscle protein anabolic response to acute exercise and protein intake in well-treated rheumatoid arthritis patients |
| Q41466368 | Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment |
| Q49387418 | Prevalence of left ventricular dysfunction in rheumatoid arthritis |
| Q35024257 | Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective |
| Q96952976 | Rheumatoid Arthritis as a Risk Factor for Coronary Artery Calcification and Obstructive Coronary Artery Disease in Patients with Chest Pain: A Registry Based Cross-Sectional Study |
| Q54949220 | Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink. |
| Q51181626 | Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. |
| Q85491939 | Rheumatoid arthritis: Predicting mortality in RA: the quest for useful information |
| Q87458461 | Rheumatoid arthritis: treating cardiovascular risk in RA requires multidisciplinary care |
| Q34746646 | Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts. |
| Q36515160 | Risk and predictors of cardiovascular disease in psoriasis: a population-based study |
| Q61815016 | Risk of Infection with Methotrexate Therapy in Inflammatory Diseases: A Systematic Review and Meta-Analysis |
| Q37442945 | Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. |
| Q35026454 | Safety and clinical efficacy of golimumab in the treatment of arthritides |
| Q33591510 | Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds |
| Q88347788 | Skeletal muscle stem cell characteristics and myonuclei content in patients with rheumatoid arthritis: a cross-sectional study |
| Q26852081 | Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis |
| Q38097749 | Statins and autoimmunity |
| Q35136753 | Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation model |
| Q34792330 | TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis |
| Q33923265 | TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies |
| Q37027093 | The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases |
| Q54965764 | Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis. |
| Q85055006 | [Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis] |
Search more.